Atai stock forecast.

5 Wall Street research analysts have issued 12-month price objectives for COMPASS Pathways' shares. Their CMPS share price targets range from $19.00 to $120.00. On average, they anticipate the company's stock price to reach $46.83 in the next year. This suggests a possible upside of 683.2% from the stock's current price.Atai Life Sciences saw a increase in short interest during the month of October. As of October 31st, there was short interest totaling 5,630,000 shares, an increase of 20.6% from the previous total of 4,670,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are ...Nov 24, 2023 · NeuBase Therapeutics' stock was trading at $3.8040 on January 1st, 2023. Since then, NBSE stock has decreased by 82.2% and is now trading at $0.6758. View the best growth stocks for 2023 here. Are investors shorting NeuBase Therapeutics? NeuBase Therapeutics saw a decrease in short interest in the month of October. NL0015000DX5. ATAI Life Sciences NV is a clinical-stage biopharmaceutical company. It engages in the treatment of mental health disorders. The company was founded by Christian Angermayer, Florian Brand, Srinivas Rao and Lars Christian Wilde in June 2018 and is headquartered in Berlin, Germany. Show more.

ATAI - ATAI Life Sciences NV Stock quote - CNNMoney.com Markets Tech Media Success Video ATAI Life Sciences NV (NASDAQ:ATAI) 1.07 Delayed Data As of 3:58pm ET -0.055 / -4.91% Today’s... 35,390.15 +117.12(+0.33%) Nasdaq -15.00(-0.11%) Russell 2000 1,807.50 +11.96(+0.67%) Crude Oil 75.54 -1.56(-2.02%) Gold 2,003.00 +10.20(+0.51%) Atai Life Sciences N.V. …Web

Price target. 13.80 0.00 0.00%. The 5 analysts offering 1 year price forecasts for ATAI have a max estimate of — and a min estimate of —. The ATA Inc. stock price gained 7.69% on the last trading day (Friday, 1st Dec 2023), rising from $1.04 to $1.12. During the last trading day the stock fluctuated 12.20% from a day low at $1.03 to a day high of $1.15. The price has risen in 5 of the last 10 days and is up by 0.9% over the past 2 weeks. Volume fell on the last day by -2 million ...

If you want to read our detailed analysis of these stocks, go directly to the 10 Best Psychedelic Stocks to Buy Now. 5. Cybin Inc. (OTC: CLXPF) Cybin Inc. (OTC: CLXPF) stock has returned more than ...Find real-time DNUT - Krispy Kreme Inc stock quotes, company profile, news and forecasts from CNN Business.ACIU Stock 12 Months Forecast. Based on 2 Wall Street analysts offering 12 month price targets for AC Immune SA in the last 3 months. The average price target is $16.00 with a high forecast of $16.00 and a low forecast of $16.00. The average price target represents a 417.80% change from the last price of $3.09.Find real-time ATAI - ATAI Life Sciences NV stock quotes, company profile, news and forecasts from CNN Business.Web

Find the latest Global Partners LP (GLP) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W - 6W. Mid ...

See Atai Life Sciences N.V. (ATAI) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.

Discover historical prices for ATAI stock on Yahoo Finance. View daily, weekly or monthly format back to when Atai Life Sciences N.V. stock was issued.Get the latest ATAI Life Sciences NV (ATAI) real-time quote, historical performance, charts, and other financial information to help you make more informed ...See ATAI Life Sciences N.V. stock price prediction for 1 year made by analysts and compare it to price changes over time to develop a better trading strategy. ... Forecast . Price target. 13.80 0.00 0.00%. The 5 analysts offering 1 year price forecasts for ATAI have a max estimate of — and a min estimate of —.CLLS Stock 12 Months Forecast. $6.33. (116.04% Upside) Based on 4 Wall Street analysts offering 12 month price targets for Cellectis SA in the last 3 months. The average price target is $6.33 with a high forecast of $10.00 and a low forecast of $3.00. The average price target represents a 116.04% change from the last price of $2.93.Dec 1, 2023 · Based on short-term price targets offered by four analysts, the average price target for atai Life Sciences N.V. comes to $13.00. The forecasts range from a low of $6.00 to a high of $20.00. The ... Get actionable alerts from top Wall Street Analysts. Find out before anyone else which stock is going to shoot up. Get powerful stock screeners & detailed portfolio analysis. Subscribe Now See Plans & Pricing. Get the latest Aptinyx Inc APTX Stock forecast and financial predictions, including earnings and sales forecast, on TipRanks.com.24. 3. 2023. ... ... predictions of future events. Although we believe that the ... Total stockholders' equity attributable to ATAI Life Sciences N.V. stockholders ...

Get ATA IMS Bhd (ATAI.KL) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments.Validation of atai's operating model and ability to capture value: IPO of COMPASS Pathways in 2020 and licensing deal between Otsuka and atai subsidiary Perception Neuroscience in 2021 Strong cash position of approx. $273M (as of December 31 st , 2022) and access to up to an additional $160m from term loan facility with Hercules 2 lead to ...Jul 28, 2022 · Atai Life Sciences. One of Atai Life Sciences' early investors was venture capitalist Peter Thiel. The company went public in June 2021 at $15 and is currently trading at $3.78 with a market cap ... 18. 6. 2021. ... Atai Life Sciences, a biotech company that uses psychedelics to treat ... Stock ScreenerNEW! Market Forecast · Options Investing; Subscribe; Sign ...Get the latest Mind Medicine (MindMed) Inc (MNMD) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.

See ATAI Life Sciences N.V. stock price prediction for 1 year made by analysts and compare it to price changes over time to develop a better trading strategy. ... Forecast . Price target. 13.80 0.00 0.00%. The 5 analysts offering 1 year price forecasts for ATAI have a max estimate of — and a min estimate of —.Atai Capital experienced a decline of 5.8% in the third quarter, bringing our year-to-date (YTD) returns to 6.5% net of all fees. This compares to a 13.1% total return for the S&P 500 YTD and a 2. ...

ATAI Life Sciences NV (ATAI) stock is trading at $3.05 as of 3:20 PM on Thursday, Dec 15, a drop of -$0.05, or -1.77% from the previous closing price of $3.10. The stock has traded between $2.98 and $3.10 so far today. Volume today is low.Atai Life Sciences ( ATAI 2.80%), a small-cap drugmaker developing psychedelic-based treatments for drug dependency and mental health disorders, posted strong gains during the first four days of ...Atai Life Sciences is forecasted to grow earnings and revenue by 20.7% and 73.6% per annum respectively. EPS is expected to grow by 29.2%. Return on equity is …WebSee the latest Vista Energy SAB de CV ADR stock price (VIST:XNYS), related ... ATAI Life Sciences, LianBio, or BioXcel Therapeutics? PR Newswire Oct 26, 2023 ...People use statistics daily for weather forecasts, predicting disease, preparing for emergencies, medical research, political campaigns, tracking sales, genetics, insurance, the stock market and quality testing.The sector offers explosive growth potential, evidenced by the recent positive coverage of psychedelic stocks by investment research firms like Citi, Credit Suisse, Canaccord Genuity, and Cantor ...7 Wall Street research analysts have issued twelve-month price targets for Mind Medicine (MindMed)'s shares. Their MNMD share price targets range from $7.00 to $75.00. On average, they anticipate the company's share price to reach $25.43 in the next year. This suggests a possible upside of 684.8% from the stock's current price.Nov 29, 2023 · Read an investment analysis of ATAI stock here. ... By 2029, it is forecast to be worth $7.2 billion globally, with a compound annual growth rate of 55%. Also, ...

Find the latest SoundHound AI, Inc. (SOUN) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W - 6W ...

Find real-time CRM - Salesforce Inc stock quotes, company profile, news and forecasts from CNN Business.

atai Life Sciences N.V. - Buy. Zacks' proprietary data indicates that atai Life Sciences N.V. is currently rated as a Zacks Rank 2 and we are expecting an above average return from the ATAI shares ...What's Happening With ATAI Life Sciences NV Stock Today? ATAI Life Sciences NV (ATAI) stock is trading at $3.05 as of 3:20 PM on Thursday, Dec 15, a drop of -$0.05, or -1.77% from the previous closing price of $3.10. The stock has traded between $2.98 and $3.10 so far today. Volume today is low.25. 10. 2023. ... ... Atai in early October, with a price target of $20. Its closing price on Oct. 24 was $1.23. The very same week, Atai announced it had ...ATAI Life Sciences NV Follow Share $1.11 Nov 22, 2:08:38 PM GMT-5 · USD · NASDAQ · Disclaimer search Compare to Cybin Inc $0.46 CYBN2.61% Compass Pathways PLC $6.00 CMPS2.92% Mind Medicine... Detailed statistics for Atai Life Sciences N.V. (ATAI) stock, including valuation metrics, financial numbers, share information and more. ... Analyst Forecast. The ...Apr 13, 2023 · Validation of atai's operating model and ability to capture value: IPO of COMPASS Pathways in 2020 and licensing deal between Otsuka and atai subsidiary Perception Neuroscience in 2021 Strong cash position of approx. $273M (as of December 31 st , 2022) and access to up to an additional $160m from term loan facility with Hercules 2 lead to ... Even in a speculative industry, I believe the stock is undervalued by these few facts alone. ATAI holds: 450M cash and cash equivalents; 20% equity stake in CMPS (750M mktcp - 150M worth at current prices); and ATAI has a vast ip pipeline that includes 9 lead compounds. Curious as to the community’s thoughts here!According to TipRanks, Palomeque has an average return of -14.1% and a 28.57% success rate on recommended stocks. Currently, the analyst consensus on ATAI Life Sciences is a Strong Buy with an average price target of $13.75.See Insiders’ Hot Stocks on TipRanks >> The company has a one-year high of $4.96 and a one-year low of $1.14. Sep 30, 2023.The average Bionano Genomics stock price prediction forecasts a potential upside of 532.91% from the current BNGO share price of $1.58. What is BNGO's forecast return on assets (ROA) for 2023-2026? (NASDAQ: BNGO) forecast ROA is N/A, which is lower than the forecast US Medical Instruments & Supplies industry average of 0.13%.This was the ETF and Ark Invest’s first purchase of ATAI stock since March 14. From March 14 to July 5, ATAI stock declined by 27%. After the recent purchases, ARKG now owns a total of 1.82 ...ATAI Life Sciences N.V. Stock Chart and Share Price Forecast, Short-Term "ATAI" Stock Prediction for Next Days and Weeks Walletinvestor.com ATAI Life Sciences N.V. (ATAI) Forecast Chart, Long-Term Predictions for Next Months and Year: 2023, 2024ATAI Life Sciences NV Stock Forecast. Is ATAI Life Sciences NV Stock Undervalued? The current ATAI Life Sciences NV [ ATAI] share price is $1.06. The Score for ATAI is 20, which is 60% below its historic median score of 50, and infers higher risk than normal. ATAI is currently trading in the 10-20% percentile range relative to its historical ...

Nov 30, 2023 · According to the issued ratings of 4 analysts in the last year, the consensus rating for Atai Life Sciences stock is Buy based on the current 4 buy ratings for ATAI. The average twelve-month price prediction for Atai Life Sciences is $12.80 with a high price target of $20.00 and a low price target of $9.00. Learn more on ATAI's analyst rating ... According to TipRanks, Palomeque has an average return of -14.1% and a 28.57% success rate on recommended stocks. Currently, the analyst consensus on ATAI Life Sciences is a Strong Buy with an average price target of $13.75.See Insiders’ Hot Stocks on TipRanks >> The company has a one-year high of $4.96 and a one-year low of $1.14. Sep 30, 2023.Cybin Inc. (OTC: CLXPF) stock has returned more than 3,485% to investors in the past twelve months. The firm operates as a life sciences company concentrating on the development of psychedelic drugs.Instagram:https://instagram. nyse bbypenny stock scamsshould i invest in shiba inucan i day trade with robinhood ATAI Life Sciences N.V. stock price forecast for further price development down to -32.20% (time horizon: 1 day) and price target of 1.11 USD. Short-term (time horizon: 2 weeks) ATAI Life Sciences N.V. share price prediction for 2024-01-12 with daily closed price projectionsPeople use statistics daily for weather forecasts, predicting disease, preparing for emergencies, medical research, political campaigns, tracking sales, genetics, insurance, the stock market and quality testing. cheap stocks on cash apptesm stock Stock Price Forecast. The 6 analysts offering 12-month price forecasts for Digital Turbine Inc have a median target of 5.50, with a high estimate of 12.00 and a low estimate of 5.00. The median ... dental plans.com review ATAI Life Sciences NV (ATAI) stock is trading at $2.17 as of 1:48 PM on Monday, Jul 17, a gain of $0.15, or 7.55% from the previous closing price of $2.02. The stock has traded between $2.00 and $2.20 so far today. Volume today is less active than usual.Nov 30, 2023 · Atai Life Sciences Announces Results from the Phase 1 Iv-To-Subcutaneous Bridging Study of Pcn-101 (R-Ketamine) Aug. 08: CI Atai Life Sciences N.V., Atai Life Sciences AG Enters into the Second Amendment to Loan and Security Agreement with the Several Banks May. 31: CI